Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, and the 5‐year survival rate was only 7.7%. To improve prognosis, a screening biomarker for early diagnosis of pancreatic cancer is in urgent need. Long non‐coding RNA (lncRNA) expression profiles as potential cancer prognostic biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jukun, Xu, Qiuyan, Zhang, Haodeng, Yin, Xinhai, Zhu, Chen, Zhao, Ke, Zhu, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947154/
https://www.ncbi.nlm.nih.gov/pubmed/29239017
http://dx.doi.org/10.1002/jcb.26598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947154/
https://www.ncbi.nlm.nih.gov/pubmed/29239017
http://dx.doi.org/10.1002/jcb.26598

Ejemplares similares